Bring Silicon Valley to Philly: Forward Thinking Trends in Healthcare
On June 2nd, Hemi hosted “Bring Silicon Valley to Philly: Forward Thinking Trends in Healthcare” in Philadelphia at the BIO International Convention 2019. We had a packed house with standing room only. In attendance were nearly 100 industry leaders who are shaking up the future of healthcare. Everyone enjoyed an exciting evening, learning the latest trends presented by Hemi portfolio founders.
- AI tools have incredible potential to impact biopharma and the way we treat data. Phenomic AI CEO, Sam Cooper, described his company’s work on AI-guided phenotypic screening.
- Blockchain is the next must-have technology for its privacy design and interoperability. Nebula Genomics CEO, Kamal Obbad, showcased blockchain-enabled consumer genomics data sharing.
- Nano Technology is breaking down barriers in biological systems. Navan CEO, Michael Nowak, explained how NanoStraws technology optimizes intracellular access.
- Next-Gen Sequencing is revamping high-throughput biology. Mendo co-founder, Nate Cira, developed the first truly portable and scalable electrically-actuated microfluidic valve.
Epigenetics is driving personalized medicine and big data analytics. Epigenomics CEO, Fergus Chan, spoke about the creation of ATAC-seq technology.
Hemi was selected to present this year’s Investor Prize at the BIO International Convention 2019. This prestigious award is a recognition of our achievements in healthcare investments. Hemi judged at the BIO Start-Up Stadium on June 4th and 5th with the mission to evaluate and vote for the most cutting-edge healthcare companies of tomorrow. The winner of Start-Up Stadium has a chance to win a one-hour advisory discussion with Hemi Ventures.
If you’d like to learn more about Hemi and our latest events, please follow us on LinkedIn. We look forward to the next opportunity to meet with you and fellow industry leaders.
